Of note, KLC1 is a favorable prognostic marker in pancreatic cancer (p < 0.001) and an unfavorable prognostic marker in renal cancer with highest median expression in gliomas (TCGA dataset). This evidence concerns the gene KLC1 and pancreatic neoplasm.